Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17154501rdf:typepubmed:Citationlld:pubmed
pubmed-article:17154501lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17154501lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:17154501lifeskim:mentionsumls-concept:C0010656lld:lifeskim
pubmed-article:17154501lifeskim:mentionsumls-concept:C0022115lld:lifeskim
pubmed-article:17154501lifeskim:mentionsumls-concept:C1537028lld:lifeskim
pubmed-article:17154501lifeskim:mentionsumls-concept:C0336791lld:lifeskim
pubmed-article:17154501pubmed:issue23lld:pubmed
pubmed-article:17154501pubmed:dateCreated2006-12-12lld:pubmed
pubmed-article:17154501pubmed:abstractTextCaspases are the unique enzymes responsible for the execution of the cell death program and may represent an exclusive target for the specific molecular imaging of apoptosis in vivo. 5-Pyrrolidinylsulfonyl isatins represent potent nonpeptidyl caspase inhibitors that may be suitable for the development of caspase binding radioligands (CBRs). (S)-5-[1-(2-Methoxymethylpyrrolidinyl)sulfonyl]isatin (7) served as a lead compound for modification of its N-1-position. Corresponding pairs of N-1-substituted 2-methoxymethyl- and 2-phenoxymethylpyrrolidinyl derivatives were examined in vitro by biochemical caspase inhibition assays. All target compounds possess high in vitro caspase inhibition potencies in the nanomolar to subnanomolar range for caspase-3 (Ki=0.2-56.1 nM). As shown for compound (S)-1-(4-(2-fluoroethoxy)benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin (35), the class of N-1-substituted 5-pyrrolidinylsulfonyl isatins competitively inhibits caspase-3. All caspase inhibitors show selectivity for the effector caspases-3 and -7 in vitro. The 2-methoxymethylpyrrolidinyl versions of the isatins appear to possess superior caspase inhibition potencies in cellular apoptosis inhibition assays compared with the 2-phenoxymethylpyrrolidinyl inhibitors.lld:pubmed
pubmed-article:17154501pubmed:languageenglld:pubmed
pubmed-article:17154501pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:citationSubsetIMlld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17154501pubmed:statusMEDLINElld:pubmed
pubmed-article:17154501pubmed:monthNovlld:pubmed
pubmed-article:17154501pubmed:issn0022-2623lld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:LevkauBodoBlld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:SchoberOtmarOlld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:SchäfersMicha...lld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:WagnerStefanSlld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:KopkaKlausKlld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:BreyholzHans-...lld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:KeulPetraPlld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:HöltkeCarsten...lld:pubmed
pubmed-article:17154501pubmed:authorpubmed-author:FaustAndreasAlld:pubmed
pubmed-article:17154501pubmed:issnTypePrintlld:pubmed
pubmed-article:17154501pubmed:day16lld:pubmed
pubmed-article:17154501pubmed:volume49lld:pubmed
pubmed-article:17154501pubmed:ownerNLMlld:pubmed
pubmed-article:17154501pubmed:authorsCompleteYlld:pubmed
pubmed-article:17154501pubmed:pagination6704-15lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:meshHeadingpubmed-meshheading:17154501...lld:pubmed
pubmed-article:17154501pubmed:year2006lld:pubmed
pubmed-article:17154501pubmed:articleTitle5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.lld:pubmed
pubmed-article:17154501pubmed:affiliationDepartment of Nuclear Medicine, University Hospital of the Westfälische Wilhelms-Universität, Münster, Germany. kopka@uni-muenster.delld:pubmed
pubmed-article:17154501pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17154501pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17154501lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17154501lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17154501lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17154501lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17154501lld:pubmed